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634 Factors influencing the effect o f  thrombolysis
Lytic activity profile of 1.5 MU streptokinase Infused 
in 60 minutes for acute myocardial infarction
J. Col, K. Al Shwafi, B. Pirenne, A. de Meester, C. Miesse, J. Renkin. 
University of Louvain Medical School, Brussels, Belgium
The two mechanisms limiting the efficiency of the thrombolytic activity of strep­
tokinase (SK) are the neutralization with specific antibodies or inhibitors and 
the plasminogen depletion with subsequent plasminogen-steal effect resulting 
from the formation of the activator (SK-plasminogen complexes). The current 
dose of 1.5 MU SK given in 60 minutes (min) was designed to overcome 
the first factor, without taking consideration to the second factor, To explore 
this, the net lytic activity (L Act) of this regimen was investigated by ex vivo 
measurement of lysis onset time (LOT) of fresh autologous thrombus using 
a bedside thrombolytic assessment system (TAS; Cardiovascular Diagnostic 
System, Inc.) before 10, 20, 60 and 180 min after start of SK infusion in 58 AMI 
pts. L Act is proportionate to shortening of LOT and is non-detectable when 
LOT >1200 seconds (sec). Lytic Reserve assessed by the LOT response to 
1,000 U/ml t-PA in vitro (normally <300 sec) was determined at baseline and 
after 180 min.
Results: LOT determinations are expressed as median.
Baseline 10 min 20 min 60 min 180 min
LOT (sec) >1200 173* 242*’ 802* 1022
% Pts LOT >1200 100 12 17 34 46°
% Pts LOT <300 0 71 62 26 27° °
LOT (sec) in vitro t-PA 106 — — — >300*
% Pts with Lytic Reserve 100 _ — — 6'
p < 0.001; 
changes.
p < 0.02 vs preceding results. ° p  = 0.0005; ° °  p < 0.0001 for sequential
Conclusions: 1) Rate of initial resistance to SK was found to be 12% most 
likely due to neutralization effect. 2) L Act was inversely related to the cumulated 
infused dose of SK, with an important impact beyond 20 min (500,000 U). 3) 
1.5 MU SK exhausted the Lytic Reserve. Plasminogen-steal effect appears 
therefore to represent the dominant limiting factor of efficient Lact.
Comparison of lytic activities during accelerated t-PA 
and streptokinase infusion in patients treated for 
acute myocardial infarction
A. de Meester, K. Al Shwafi, B. Pirenne, C. Miesse, J. Renkin, J. Col. 
University of Louvain Medical School, Brussels, Belgium
Based on eariy infarct-related coronary patency and mortality, accelerated t-PA 
was established superior to the 60-min infusion of 1.5 MU of streptokinase (SK) 
in acute myocardial infarction (AMI) (Gusto 1). Although the fibrin specificity 
may explain in part the better efficacy of t-PA, it has not been demonstrated 
at the level of lysis activation. Accordingly, to compare lytic activities of two 
different thrombolytic agents, lysis onset time (LOT) of a fresh autologous 
thrombus was determined ex-vivo using a bedside thrombolytic assessment 
test (TAS; Cardiovascular Diagnostics inc., USA) at baseline, 10 min after 
bolus, end of infusion, 180 min, in 58 pts with AMI treated with 1.5 MU SK and 
61 pts with accelerated t-PA. Lytic activity (L Act) is inversely proportional to 
LOT.
Results: After t-PA bolus, LOT decreased <300 sec in 98% of pts and after 
SK in 71% (p = 0.002), Using the threshold of LOT <300 sec as the one 
observed in 98% of pts given t-PA, the L Act during infusion remained more 
efficient with t-PA than with SK. By contrast, at 180 min, efficient L Act is still 
present in more pts treated with SK.
% oí pts with LOT <300 sec
Baseline 10 min 20 min End Infusion 180 min
t-PA 0% 98% — 8B% 3%
SK 0% 71% 62% 26%“ 28% ‘
p = 0.002’, p < 0.001 versus t-PA
Conclusions: 1) unlike previous hematologic assays, this new method of 
assessment of L Act provides a direct evidence of the biological superiority 
of t-PA over SK related to the higher infarct-related coronary patency rate, 
achieved at 90 min with t-PA; 2) sustained L Act beyond 90 min observed with 
SK is consistent with a lower rate of early reocclusion.
Smoker’s paradox in acute myocardial infarction: no 
relation to higher patency rates after intravenous 
thrombolysis, primary PTCA or spontaneous 
reperfusion
D, Himbert, J.-M. Juliard, H. Benamer, L. J. Feldman, G. Steg. Hôpital Bichat, 
Paris, France
It has been suggested that compared to nonsmokers (NSM), smokers (SM) with 
acute myocardial infarction (AMI) have a more favorable prognosis, and that 
this “smoker’s paradox” may be related to a larger contribution of thrombosis 
to acute coronary occlusion. Therefore, SM may have less extensive coronary 
artery disease, and superior sensitivity to reperfusion interventions.
To investigate this issue, we examined 790 consecutive patients (pts) ad­
mitted <6 hours after onset of AML Of these pts, 555 (70%) were SM, and 
235 (30%) NSM. Acute angiography was performed in all pts, after either intra­
venous thrombolysis (with standby rescue PTCA), primary PTCA, or suspected 
spontaneous reperfusion.
Smokers Nonsmokers P
Age (years) 56 67 <10“ 5
Male 502 (91%) 142 (60%) <0.01
Multivessel disease 236 (42%) 113 (48%) NS
Cardiogenic shock 18 (3%) 18 (8%) <0.01
Spontaneous reperìusion 42 (8%) 19 (8%) NS
Thrombolysis
-  Attempted 258 {46%) 7 6(32%) <0.001
-  Success, pre-Rescue PTCA 169 (66%) 50 (66%) NS
-Success, post-Rescue PTCA 235 (91%) 64 (84%) NS
Primary PTCA
-  Attempted 243 (44%) 125 (53%) <0.02
-  Success 226 (93%) 120 (96%) NS
Reperfusion, overall 503 (91%) 203 (86%) NS
In-hospital mortality 26 (5%) 37 (16%) <10~5
Conclusions: Since there is no difference between groups in terms of spon­
taneous, post-thrombolysis or post-PTCA patency rates during AMI, the higher 
mortality observed in NSM compared to SM appears mainly related to worse 
baseline characteristics.
After thrombolytic therapy smokers with complex 
culprit lesions have lower reocclusion rates than 
non-smokers
G. Veen, C.C. De Cock, F.W.A. Verheugt. Department of Cardiology, Free 
University Hospital, Amsterdam, The Netherlands, Radboud University 
Hospital, Nijmegen, The Netherlands
In the APRICOT-study the primary endpoint was reocclusion of culprit coronary 
lesions at 3 months after successful thrombolysis. In this study a total of 248 
patients (pts) underwent coronary angiography within 48 hours after successful 
thrombolysis and after 3 months. The morphology of the culprit lesion at the first 
angiography was prespecified as smooth or complex. Changes in morphology 
and severity were related to baseline clinical and demographic characteristics.
Results: Among the 108 pts with complex culprit lesions 61 pts smoked and 
47 did not. Of the 61 smokers 9 (15%) had reocclusion. Of the 47 non-smokers 
15 (32%) had reocclusion (p < 0.05). Of the 84 pts with complex lesions 
without reocclusion 51 were smoker and 33 were not. Of the 51 smokers 28 
(74%) showed a favourable change to smooth morphology with a concomitant 
reduction in severity. Of the 33 non-smokers this change occurred in 10 pts 
(26%) (p < 0.05). These differences were not seen in pts with smooth culprit 
lesions.
in conclusion, after thrombolysis for acute myocardial Infarction smoking 
is associated with a favourable remodelling of complex culprit lesions with a 
concomitant reduction in severity and a lower reocclusion rate. Possibly, the 
hypercoagulable state that has been shown to exist in smokers, accounts for 
a larger thrombotic component in complex lesions seen after thrombolysis. 
These lesions are more subject to ongoing thrombus resolution.
